Transfer learning across the EC classification hierarchy overcomes data scarcity in drug-target interaction prediction

Predicting drug-target interactions (DTIs) with deep learning offers opportunities to accelerate drug discovery, yet performance is often constrained by the scarcity of target-specific training data. Transfer learning relieves this limitation but requires choosing a relevant source task, a choice usually made ad hoc. Here we use the Enzyme Commission (EC) classification hierarchy as a systematic criterion for source selection, ascending the EC tree from the target enzyme until a related family carries sufficient ChEMBL bioactivity data to pre-train a deep feedforward network, which is then fine-tuned on the scarce target. We applied this approach to SHMT2 and MTHFD2, two pharmacologically understudied enzymes of the mitochondrial one-carbon (1C) pathway, which is implicated in cancer and fibrosis and supports fibroblast collagen production through glycine synthesis. With 29 active compounds for MTHFD2 and only 6 for SHMT2 which has no ligands of its own, the six coming from its paralogue SHMT1 in the same EC class. EC-guided transfer learning produced usable models in a system where training from scratch failed (Matthews correlation coefficient 0.00 for SHMT2). Virtual screening of the DrugBank library identified six candidates, three of which, carbimazole, crizotinib, and GSK-2018682, reduced TGF-β-induced collagen production and glycine accumulation in human lung fibroblasts. The methodology, datasets, and code are released as a reusable template for enzyme targets with scarce bioactivity coverage.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-10999675/v1
Primary Topic
Computational Drug Discovery Methods
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Transfer learning across the EC classification hierarchy overcomes data scarcity in drug-target interaction prediction

Rengül Çetin-Atalay, Volkan Atalay, Obada R. Shamaa, Robert B. Hamanaka et al.
Research Square
Computational Drug Discovery Methods
preprint

Transfer learning across the EC classification hierarchy overcomes data scarcity in drug-target interaction prediction

Rengül Çetin-Atalay, Volkan Atalay, Obada R. Shamaa, Robert B. Hamanaka, Alperen Dalkıran, Parker S. Woods, Takugo Cho, Angelo Y. Meliton, Kun Woo D Shin, Gökhan M. Mutlu
preprint en

Abstract

Predicting drug-target interactions (DTIs) with deep learning offers opportunities to accelerate drug discovery, yet performance is often constrained by the scarcity of target-specific training data. Transfer learning relieves this limitation but requires choosing a relevant source task, a choice usually made ad hoc. Here we use the Enzyme Commission (EC) classification hierarchy as a systematic criterion for source selection, ascending the EC tree from the target enzyme until a related family carries sufficient ChEMBL bioactivity data to pre-train a deep feedforward network, which is then fine-tuned on the scarce target. We applied this approach to SHMT2 and MTHFD2, two pharmacologically understudied enzymes of the mitochondrial one-carbon (1C) pathway, which is implicated in cancer and fibrosis and supports fibroblast collagen production through glycine synthesis. With 29 active compounds for MTHFD2 and only 6 for SHMT2 which has no ligands of its own, the six coming from its paralogue SHMT1 in the same EC class. EC-guided transfer learning produced usable models in a system where training from scratch failed (Matthews correlation coefficient 0.00 for SHMT2). Virtual screening of the DrugBank library identified six candidates, three of which, carbimazole, crizotinib, and GSK-2018682, reduced TGF-β-induced collagen production and glycine accumulation in human lung fibroblasts. The methodology, datasets, and code are released as a reusable template for enzyme targets with scarce bioactivity coverage.

Research Square
Middle East Technical University (TR), University of Chicago (US), University of Edinburgh (GB)
U.S. Department of Defense, Orta Doğu Teknik Üniversitesi
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon